PRESS RELEASE
D2 Solutions Adds Real-Time Prior Authorization Text Message Updates for Patients
Critical addition to D2's UltraTouch Verify platform improves patient experience while reducing manual burden for pharmacies and hubs
Saint Charles, Mo. — May 12, 2026 — D2 Solutions, a healthcare consulting and technology company focused on improving patient access to specialty therapies, announced its UltraTouch® Verify platform will now deliver automated, real-time prior authorization (PA) updates to patients via text message. The capability helps patients stay informed throughout the PA process while reducing the volume of manual inquiries pharmacies and patient support teams must manage.
Prior authorization delays remain a common barrier to therapy access, a challenge validated by the fact that 97% of practices report medically necessary care is delayed or denied due to these administrative hurdles. With physicians and their staff spending an average of 13 hours per week navigating these requests, patients are often left without visibility into the status of their prescriptions during critical waiting periods.
“What we’re doing is meaningful for everyone involved, but especially for patients,” said Jim Maguire, CIO and CTO of D2 Solutions. “Prior authorization can be confusing, and this update makes it easier for patients to understand what’s happening with their therapy while helping pharmacies reduce the burden of manual status checks.”
A recent D2 survey found that prior authorization is a significant barrier to care. Nearly half of all adults, 47%, reported that their insurance required PA, with 22% facing unexpected delays.
Already in use by a specialty brand in allergy therapeutics, the new texting capability helps improve communication between support teams and the patients they serve. By replacing manual outreach with automated, real-time updates, the enhancement keeps patients informed throughout the PA process while reducing administrative burden on pharmacy and hub staff.
-
Customized brand messaging: Hubs and pharmacies can send patient text updates customized by brand.
-
Real-time PA updates: Patients receive automated text notifications as their prior authorization is processed.
- Patient choice at enrollment: Patients can opt in or opt out of text messaging at enrollment.
- API-enabled integration: The update can integrate with CRM or patient EMR systems.
By proactively delivering status updates, the new capability can also help reduce inbound status-check calls and support a more transparent prior authorization process.
UltraTouch® Verify is part of D2 Solutions’ broader suite of healthcare technology solutions designed to support manufacturers, pharmacies, and patient support programs throughout the specialty therapy lifecycle. By combining advisory expertise with purpose-built technology, D2 Solutions helps organizations navigate the operational and regulatory complexities involved in bringing specialty therapies to patients.
For more information on D2 Solutions' latest product innovations, visit d2rx.com.
###
About D2 Solutions
D2 Solutions is a healthcare and pharma commercialization partner focused on accelerating patient access to specialty therapies. By combining strategic advisory services with proprietary technology, D2 Solutions works to reduce friction between manufacturers, pharmacies and payers. From streamlining market access and prior authorization to supporting regulatory compliance and accreditation, the D2 Solutions platform is designed to optimize the specialty drug lifecycle and help patients access the therapies they need. Learn more at d2rx.com.
Media Contact
PANBlast PR for D2 Solutions
